A epidermólise bolhosa herdada (EB) abrange uma série de distúrbios caracterizados pela formação recorrente de bolhas como resultado da fragilidade estrutural da pele e de outros tecidos selecionados.
Introdução
O que você precisa saber de cara
A epidermólise bolhosa hereditária é uma doença genética rara caracterizada por extrema fragilidade da pele e mucosas, provocando a formação recorrente de bolhas e lesões. Ela é popularmente chamada de 'doença borboleta' ou 'pele de borboleta', afetando também unhas, dentes e outros órgãos internos. No Brasil, o Ministério da Saúde conta com uma diretriz clínica oficial aprovada pela CONITEC, embora não haja medicamentos específicos listados como dispensados pelo SUS. Pesquisas clínicas internacionais continuam em andamento para avaliar novas abordagens de tratamento e controle dos sintomas.
A epidermólise bolhosa herdada (EB) abrange uma série de distúrbios caracterizados pela formação recorrente de bolhas como resultado da fragilidade estrutural da pele e de outros tecidos selecionados.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 166 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 443 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
20 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.
Curadoria gene-doença
fontes oficiaisNaxos disease
An autosomal recessive disorder characterized by the association of diffuse non-epidermolytic palmoplantar keratoderma with woolly hair and cardiac abnormalities such as dilated cardiomyopathy and arrhythmogenic right ventricular dysplasia.
Epidermolysis bullosa, junctional 4, intermediate
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB4 is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur. JEB4 patients manifest blisters at birth or shortly afterward. Blisters may heal with atrophic scarring and variable hypo- or hyperpigmentation. Oral mucosa may be involved.
Keratoderma, palmoplantar, striate 2
A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present.
Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS4 is an autosomal recessive disorder characterized by mild skin fragility with onset at birth or in early childhood, associated with acral blistering with hemorrhagic crusts. Skin fragility improves with age in most patients, although mottled pigmentation may later develop on the trunk and proximal limbs.
Epidermolysis bullosa, junctional 5A, intermediate
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB5A is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur.
Epidermolysis bullosa simplex 7, with nephropathy and deafness
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS7 is an autosomal recessive disorder characterized by the association of skin blistering, hereditary nephritis, sensorineural deafness, and beta-thalassemia minor. Skin blistering is present at birth, particularly in the tibial area but also scattered on other parts of the body.
Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS6 is an autosomal dominant disorder presenting at birth with extensive skin defects on the extremities, leaving behind hypopigmentation and atrophy with a whirled pattern. Cutaneous fragility and generalized blistering persist during childhood and decrease in adulthood. Adult patients have dyspigmentation and atrophy of the skin, scars, follicular atrophoderma, sparse body hair, progressive diffuse alopecia of the scalp, diffuse palmoplantar keratoderma, and nail changes.
Neuropathy, hereditary sensory and autonomic, 6
A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN6 is a severe autosomal recessive disorder characterized by neonatal hypotonia, respiratory and feeding difficulties, lack of psychomotor development, and autonomic abnormalities including labile cardiovascular function, lack of corneal reflexes leading to corneal scarring, areflexia, and absent axonal flare response after intradermal histamine injection.
Kindler syndrome
An autosomal recessive skin disorder characterized by skin blistering, photosensitivity, progressive poikiloderma, and extensive skin atrophy. Additional clinical features include gingival erosions, ocular, esophageal, gastrointestinal and urogenital involvement, and an increased risk of mucocutaneous malignancy.
Epidermolysis bullosa, junctional 6, with pyloric atresia
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB6 is an autosomal recessive form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. Clinical manifestations include severe blistering, atrophic scarring, nail dystrophy, and pyloric atresia. Congenital absence of skin (aplasia cutis congenita) is common, and ear anomalies are also relatively common. Disease course is usually severe and often lethal in the neonatal period.
Epidermolysis bullosa, junctional 3A, intermediate
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB3A is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur.
Epidermolysis bullosa, junctional 2A, intermediate
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB2A is an autosomal recessive, intermediate form in which blistering lesions occur between the epidermis and the dermis at the lamina lucida level of the basement membrane zone. In intermediate forms of junctional epidermolysis bullosa, blistering does not lead to the formation of chronic granulation tissue and does not affect the lifespan of affected individuals. Nail dystrophy and dental enamel defects are present. Scarring or non-scarring alopecia and diffuse hair loss may occur.
Epidermolysis bullosa simplex 1A, generalized severe
A form of epidermolysis bullosa simplex, a group of skin fragility disorders characterized by skin blistering due to cleavage within the basal layer of keratinocytes, and erosions caused by minor mechanical trauma. There is a broad spectrum of clinical severity ranging from minor blistering on the feet, to subtypes with extracutaneous involvement and a lethal outcome. EBS1A is an autosomal dominant form characterized by generalized intraepidermal skin blistering that begins and is very prominent at birth. EBS1A may be life-threatening in the first year of life. Tendency to blistering diminishes in adolescence.
Ectodermal dysplasia-skin fragility syndrome
A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Characterized by features of both cutaneous fragility and congenital ectodermal dysplasia affecting skin, hair and nails. There is no evidence of significant abnormalities in other epithelia or tissues. Desmosomes in the skin are small and poorly formed with widening of keratinocyte intercellular spaces and perturbed desmosome/keratin intermediate filament interactions.
Epidermolysis bullosa, junctional 1B, severe
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. Junctional epidermolysis bullosa is characterized by blistering that occurs at the level of the lamina lucida in the skin basement membrane. JEB1B is an autosomal recessive, severe form characterized by bullous lesions appearing at birth, and extensive denudation of skin and mucous membranes that may be hemorrhagic. Death occurs usually within the first six months of life. Occasionally, children survive to teens.
Epidermolysis bullosa simplex 5C, with pyloric atresia
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS5C is an autosomal recessive disorder characterized by severe skin blistering at birth and congenital pyloric atresia. Death usually occurs in infancy.
Epidermolysis bullosa simplex 2A, generalized severe
A form of epidermolysis bullosa simplex, a group of skin fragility disorders characterized by skin blistering due to cleavage within the basal layer of keratinocytes, and erosions caused by minor mechanical trauma. There is a broad spectrum of clinical severity ranging from minor blistering on the feet, to subtypes with extracutaneous involvement and a lethal outcome. EBS2A is an autosomal dominant, severe form characterized by extensive intraepidermal blistering from the time of birth with herpetiform marginal spreading and central healing. Oral mucosal involvement, nail dystrophy, onychogryposis, formation of milia, and palmoplantar hyperkeratosis are common features.
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. JEB7 is an autosomal recessive form associated with congenital nephrotic syndrome and interstitial lung disease. The respiratory and renal features predominate, and lung involvement accounts for the lethal course of the disease.
Medicamentos e terapias
Mecanismo: Muscarinic acetylcholine receptor M3 antagonist
Mecanismo: DOPA decarboxylase inhibitor
Mecanismo: DOPA decarboxylase inhibitor
Mecanismo: Muscarinic acetylcholine receptor M3 antagonist
Mecanismo: Beta-2 adrenergic receptor agonist
Mecanismo: Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
Mecanismo: Adrenergic receptor alpha-2 agonist
Mecanismo: Growth hormone receptor agonist
Mecanismo: Phosphodiesterase 4 inhibitor
Variantes genéticas (ClinVar)
1.428 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
54 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Epidermólise bolhosa hereditária
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Com ensaio aberto em 1 país. O ponto verde marca onde há vaga agora.
🟢 Recrutando agora
1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
5 ensaios clínicos encontrados, 1 ativos.
Publicações mais relevantes
The lived experience and supportive care needs of Australian parents caring for children with Epidermolysis Bullosa: a qualitative descriptive analysis.
Inherited epidermolysis bullosa (EB) is a rare, incurable genodermatosis characterised with recurrent skin blistering and mucosal fragility. Wound care and nursing are critical to everyday lives of children living with EB, while the profound effect of caring for a child with a painful genetic condition leaves a significant effect on quality of life of parents and the family. This study aimed to better understand the lived experiences and supportive care needs of parents of children with EB in Australia. Interpretative phenomenological analysis was used, and semi structured focus groups interviews were conducted with Australian parents of children with EB. This included 18 parents of children with EB simplex (EBS), 9 parents of children with Junctional EB (JEB) and 16 parents of children with Dystrophic EB (DEB). The data were thematically analysed, all participants are residents of Australia and therefore reflect the services in this geographical location. Six overarching themes included: practical needs, emotional needs, informational needs, psychological needs, social needs and physical needs. Parents caring for a child with EB in Australia face numerous needs and challenges regardless of EB severity which highlights the need for provision of better more comprehensive services to deliver family focused holistic EB care that can alleviate some of the burden of EB and improve the quality of life for families and individuals living with EB.
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.
Inherited Epidermolysis Bullosa (EB) is a group of rare, genetic skin diseases characterized by extreme fragility of the skin and mucous membranes, leading to blistering and wounds in response to minimal trauma or friction. These clinical manifestations significantly reduce health-related quality of life (HRQoL). The objective of this protocol article is to provide information about the methods planned to be used to assess the measurement properties of HRQoL instruments specifically developed for EB patients of all age groups through a systematic review and meta-analysis. The protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols (PRISMA-P) guideline. The literature search will be conducted in PubMed, Web of Science (WOS) and EMBASE, including terminology that aligns with the four key elements of the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) research question (construct, target population, measurement properties and type of PROM), as well as the terminology proposed by COSMIN for measurement properties. Studies that include information on measurement properties (specifically, validity and/or reliability) with a sample of patients with inherited EB will be selected. Both title and abstract screening and full text review, will be conducted by two independent reviewers using the Rayyan tool. In addition, the risk of bias will be assessed using the COSMIN-Risk of Bias checklist. The data from each study and each measurement property will be summarized in accordance with the COSMIN guidelines. The evidence gathered will strive to adjudicate data on measurements properties of HRQoL instruments used in EB patients, and the limitations of the future systematic review will be discussed. Ultimately, results of the future systematic review will help develop more personalized guidelines for the assessment of HRQoL in EB patients of all age groups. The protocol is registered in OSF with registration number vrm87: https://osf.io/vrm87/.
Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion.
Inherited epidermolysis bullosa (EB) is a heterogeneous clinical entity that includes over 30 phenotypically and/or genotypically distinct inherited disorders, characterized by mechanical skin fragility and bullae formation. Junctional EB (JEB) is an autosomal recessive disease characterized by an intermediated cleavage level within the skin layers, commonly at the "lamina lucida". Laryngo-onycho-cutaneous syndrome (LOC) is an extremely rare variant of JEB, characterized by granulation tissue formation in specific body sites (skin, larynx, and nails). Although most cases of JEB are caused by pathogenic variants occurring in the genes encoding for classical components of the lamina lucida, such as laminin 332 (LAMA3, LAMB3, LAMC2), integrin α6β4 (ITGA6, ITGB4), and collagen XVII (COL17A1), other variants have also been described. We report the case of a 4-month-old male infant who presented with recurrent bullous and erosive lesions from the first month of life. At the first dermatological evaluation, the patient was agitated and exhibited hoarse breathing, a clinical sign suggestive of laryngeal involvement. Multiple polygonal skin erosions were observed on the cheeks, along with similar isolated, roundish lesions on the scalp and legs. Notably, nail dystrophy and near-complete anonychia were evident on the left first and fifth toes. Due to the coexistence of skin erosions and nail dystrophy in such a young infant, a congenital bullous disorder was suspected, prompting molecular analysis of all potentially involved genes. In the patient's DNA, clinical exome sequencing (CES) identified a pathogenic variant, apparently in homozygosity, in the exon 1 of the LAMA3 gene (18q11.2; NM_000227.6): c.47G > A;p.Trp16*. The presence of this variant was confirmed, in heterozygosity, in the genomic DNA of the patient's mother, while it was absent in the father's DNA. Subsequently, trio-based SNP array analysis was performed, revealing a paternally derived pathogenic microdeletion encompassing the LAMA3 locus (18q11.2). To our knowledge, this is the first reported case of JEB with a LOC-like phenotype caused by a maternally inherited monoallelic nonsense mutation in LAMA3, unmasked by an almost complete deletion of the paternal allele. The combined use of exome sequencing and SNP array is proving essential for elucidating autosomal recessive diseases with a discordant segregation. This is pivotal for providing accurate genetic counseling to parents regarding future pregnancies.
Clinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa.
Inherited epidermolysis bullosa (EB) comprises a group of genetic disorders characterized by fragile skin that blisters easily. Targeted therapies for EB necessitate personalized approaches, underscoring the importance of precise diagnostics through genetic analysis and skin biopsy using transmission electron microscopy and/or immunohistochemistry. This study highlights the application of whole-exome sequencing (WES) to identify key pathogenic variants associated with EB. Most identified variants were associated with the recessive form of dystrophic EB, including four novel COL7A1 mutations: p.Leu1488ArgfsTer222, c.7759-3C>G, p.Gln1886Ter, and c.6501+6T>C, as well as recurrent variants p.Lys142Arg and p.Gly2049Glu. Additionally, variants were detected in KRT5 (c.971T>C, p.Val324Ala), associated with EB simplex, and in LAMB3 (c.2500C>T, p.Gln834Ter) in the homozygous state, associated with junctional EB. In silico splice prediction tools suggested disrupted splicing in both cases. One patient received topical gentamicin therapy targeting the nonsense mutation p.Gln1886Ter. These findings underscore the utility of WES in EB diagnostics, broaden the mutation spectrum, and contribute to the understanding of genotype-phenotype correlations in adult patients with EB.
An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa.
Background: Inherited epidermolysis bullosa (EB) includes a group of rare genetic disorders affecting the skin and mucous membranes. These disorders are characterized by extreme fragility and blister formation after minimal or no trauma. Oral and systemic manifestations vary by subtype; the more severe forms often present with extensive intra-oral blistering, scarring, microstomia, vestibular obliteration, ankyloglossia, and-in some cases-oral cancer. This study aims to collect data on oral-health practices and challenges in people with EB to inform preventive strategies and dental care. Methods: An international, structured online questionnaire with 31 items was distributed to individuals with a confirmed diagnosis of EB. The survey explored clinical and oral manifestations, home-care routines (oral hygiene and diet), experiences with dental professionals, and the impact of oral health on quality of life. Results: Eighty-two questionnaires were completed. Dystrophic EB was the most often reported subtype (69.5%). Most respondents (67.1%) experienced recurrent oral blisters and/or erosions. Many reported relying exclusively on soft foods and struggling with mechanical plaque removal because of microstomia and pseudo-syndactyly. Severe oral pain hindered effective brushing in 17% of participants. Hand contractures and microstomia interfered with oral hygiene in 74% and 31% of participants, respectively. Nearly 30% sought dental care only when in pain. Among those who did not attend regular check-ups or hygiene sessions (44.6%), the most cited reason was that dental clinics were inadequately equipped or trained to manage EB. Conclusions: Because dental procedures carry significant risks for patients with EB, preventive care should begin in early childhood. Yet many patients are still insufficiently informed about essential preventive measures and lack access to dental professionals trained in EB management.
Publicações recentes
Topical Gentamicin in the Management of Bart Syndrome: A Case Report.
The lived experience and supportive care needs of Australian parents caring for children with Epidermolysis Bullosa: a qualitative descriptive analysis.
An International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa.
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.
Stem cell therapy: a promising frontier in modern medicine with a comprehensive overview of their biology and potential therapeutic applications in chronic non-healing cutaneous injuries.
📚 EuropePMC97 artigos no totalmostrando 85
The lived experience and supportive care needs of Australian parents caring for children with Epidermolysis Bullosa: a qualitative descriptive analysis.
Orphanet journal of rare diseasesAn International Online Survey on Oral Hygiene Issues in Patients with Epidermolysis Bullosa.
Dentistry journalMeasurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol.
PloS oneStem cell therapy: a promising frontier in modern medicine with a comprehensive overview of their biology and potential therapeutic applications in chronic non-healing cutaneous injuries.
InflammopharmacologyJunctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion.
International journal of molecular sciencesLocally Advanced Cervical Cancer in a Patient with Epidermolysis Bullosa Treated with Concurrent Chemoradiotherapy and Electronic Brachytherapy.
Reports (MDPI)Treatment progress of inherited epidermolysis bullosa.
Expert opinion on biological therapyClinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa.
International journal of molecular sciencesMissense and Inframe Pathogenic Variants in PLEC Lead to Minimal or Delayed-Onset Muscular Dystrophy in Autosomal Recessive Epidermolysis Bullosa Simplex: A Genotype-Phenotype Correlation in Nine Cases.
The Journal of dermatologyManagement of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline.
The British journal of dermatologyA pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa.
BMC medical genomicsColchicine as a treatment option for inherited epidermolysis bullosa.
Clinical and experimental dermatologyCorrelation between measured oral health and oral health-related quality of life in people with epidermolysis bullosa: a prospective cohort study.
BMC oral healthOral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases.
Journal of the European Academy of Dermatology and Venereology : JEADVEpidemiological Characteristics of Inherited Epidermolysis Bullosa in an Eastern European Population.
Journal of clinical medicineDescriptive Study of the Clinical and Molecular Features of Epidermolysis Bullosa Patients in a Romanian European Reference Network-Skin Affiliated Reference Center.
CureusExperience of dupilumab treatment in inherited epidermolysis bullosa: A short series.
Journal of the American Academy of Dermatology"Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires.
Italian journal of pediatricsBattling a rarity: A case of kindler syndrome from a developing country.
SAGE open medical case reportsDiagnosis, Management, and Outcome of Bart's Syndrome Observed in a Sub-Saharan African Country (Senegal, Dakar): 2 Case Reports.
Case reports in dermatologyA case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab.
The Journal of dermatological treatmentConsensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa.
Orphanet journal of rare diseasesPhenotype and genotype correlation of inherited epidermolysis bullosa in Indonesia.
The Australasian journal of dermatologyIntegrin alpha 6 homozygous splice-site mutation causes a new form of junctional epidermolysis bullosa in Charolais cattle.
Genetics, selection, evolution : GSEInherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
Indian journal of pathology & microbiology[Genome Editing in Therapy of Genodermatoses].
Molekuliarnaia biologiiaDiverse clinical and genetic characteristics of six cases of inherited epidermolysis bullosa.
Experimental and therapeutic medicineOral health status in patients with inherited epidermolysis bullosa: a comparative multicenter study.
Quintessence international (Berlin, Germany : 1985)Epidemiology of inherited epidermolysis bullosa in Germany.
Journal of the European Academy of Dermatology and Venereology : JEADVEye Involvement and Management in Inherited Epidermolysis Bullosa.
DrugsBurden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France.
Journal of the European Academy of Dermatology and Venereology : JEADVPotential di-genic contribution to guttate leukoderma as the predominant feature of epidermolysis bullosa simplex.
Experimental dermatologyFolliculitis decalvans and dystrophic epidermolysis bullosa: a significant association.
The British journal of dermatologyStomatological management and implant-supported rehabilitation in a patient with recessive dystrophic epidermolysis bullosa.
Clinical case reportsSquamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
CellsMultidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center.
Italian journal of pediatricsINHERITED EPIDERMOLYSIS BULLOSA IN NEWBORN (CASE STUDY).
Wiadomosci lekarskie (Warsaw, Poland : 1960)Oral status in patients with inherited epidermolysis bullosa: A multicentric observational study.
Journal of the American Academy of DermatologyCase of inherited epidermolysis bullosa simplex with KLHL24 gene mutation in Japan.
The Journal of dermatologyPractical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases.
Journal of the European Academy of Dermatology and Venereology : JEADVInherited epidermolysis bullosa: epidemiology and patient care in Slovenia with a review of the updated classification.
Acta dermatovenerologica Alpina, Pannonica, et AdriaticaA Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.
Antibodies (Basel, Switzerland)Prevalence and antimicrobial resistance profile of Staphylococcus aureus in inherited epidermolysis bullosa: a cross-sectional multicenter study in Brazil.
International journal of dermatologyPeriodontal Manifestation in a Patient with Kindler Syndrome.
Case reports in dentistryEpigenetic and metabolic regulation of epidermal homeostasis.
Experimental dermatologyImmunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up.
Journal of the European Academy of Dermatology and Venereology : JEADVClinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric DentistryA novel frameshift mutation in the FERMT1 gene in a Chinese patient with Kindler syndrome.
Experimental and therapeutic medicineEmaciation, Congestive Heart Failure, and Systemic Amyloidosis in Severe Recessive Dystrophic Epidermolysis Bullosa: Possible Internal Complications Due to Skin-Derived Inflammatory Cytokines Derived from the Injured Skin.
Dermatopathology (Basel, Switzerland)Genotypic and Phenotypic Analysis of 34 Cases of Inherited Junctional Epidermolysis Bullosa caused by COL17A1 Mutations.
The British journal of dermatologyInherited epidermolysis bullosa: update on the clinical and genetic aspects.
Anais brasileiros de dermatologiaThe photobiomodulation therapy together with the use of cord blood platelet gel could be safely suggested as primary treatment for oral lesions in patients with inherited epidermolysis bullosa.
Photodermatology, photoimmunology & photomedicineSuccessful dapsone therapy in inherited epidermolysis bullosa.
Journal of the European Academy of Dermatology and Venereology : JEADVConsensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.
The British journal of dermatologyHoarse cry in a newborn with epidermolysis bullosa simplex, generalized severe.
Pediatric dermatologyBullous Diseases in Children: A Review of Clinical Features and Treatment Options.
Paediatric drugsOccupational therapy for epidermolysis bullosa: clinical practice guidelines.
Orphanet journal of rare diseasesA nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management.
Clinical nutrition (Edinburgh, Scotland)A retrospective cohort study evaluating the accuracy of clinical diagnosis compared with immunofluorescence and electron microscopy in children with inherited epidermolysis bullosa.
The British journal of dermatologyInherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography.
Journal of the European Academy of Dermatology and Venereology : JEADV[Inherited epidermolysis bullosa].
Arkhiv patologiiCord blood platelet gel for the treatment of inherited epidermolysis bullosa.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for HaemapheresisInherited epidermolysis bullosa: New diagnostics and new clinical phenotypes.
Experimental dermatologyBurnlike scars: A sign suggestive of KLHL24-related epidermolysis bullosa simplex.
Pediatric dermatologyAdvances in understanding the molecular basis of skin fragility.
F1000ResearchIL-6/IL-10 Ratio as A Prognostic and Predictive Marker of the Severity of Inherited Epidermolysis Bullosa.
Iranian journal of immunology : IJIDiagnosis of Inherited Epidermolysis Bullosa in Resource-Limited Settings: Immunohistochemistry Revisited.
Dermatology (Basel, Switzerland)Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases.
Experimental dermatologyPain and quality of life evaluation in patients with localized epidermolysis bullosa simplex.
Orphanet journal of rare diseasesBullous, pseudobullous, & pustular dermatoses.
Seminars in diagnostic pathologyDevelopment of a clinical diagnostic matrix for characterizing inherited epidermolysis bullosa.
The British journal of dermatologyAutoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.
International journal of molecular sciencesInherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
Orphanet journal of rare diseasesEpidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry.
JAMA dermatologyResearch Techniques Made Simple: Immunofluorescence Antigen Mapping in Epidermolysis Bullosa.
The Journal of investigative dermatologyKaposi varicelliform eruption in a patient with epidermolysis bullosa simplex generalized severe.
JAAD case reportsMolecular therapies for inherited epidermolysis bullosa.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografiaOral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.
Orphanet journal of rare diseasesTreatment of feet deformities in epidermolysis bullosa.
International orthopaedicsIdentification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia.
Experimental dermatologyProinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa.
MedicineGeneralized severe junctional epidermolysis bullosa with congenital absence of skin in churra lambs.
Veterinary dermatologySystemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial.
Journal of the American Academy of DermatologyPain care for patients with epidermolysis bullosa: best care practice guidelines.
BMC medicineOral erythromycin therapy in epidermolysis bullosa simplex generalized severe.
The British journal of dermatologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Epidermólise bolhosa hereditária.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Epidermólise bolhosa hereditária e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
Existe um documento oficial para "Epidermólise Bolhosa". Ele pode não cobrir esta forma específica da doença — confira no texto do protocolo antes de contar com ele.
A condição é causada por mutações genéticas hereditárias em genes estruturais, como COL7A1, COL17A1, DSP e outros. Essas mutações enfraquecem a união entre as camadas celulares, gerando extrema fragilidade mecânica e bolhas recorrentes.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
7 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Epidermólise bolhosa hereditária. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/epidermolise-bolhosa-hereditaria
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
Epidermólise bolhosa hereditária
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- NIH/GARD
- fonte: GARD (NIH)
- Dado público estruturado
- fonte: Wikidata
- Moléculas estudadas na doença
- fonte: OpenTargets
- Ensaios clínicos
- fonte: ClinicalTrials.gov